Library Home | Reset filters
Select one or more filter options and click search below.
Reset filters
AUTHOR(S) Ting Shi; Jiafeng Pan; Emily Moore (et al.)
There is considerable policy, clinical and public interest about whether children should be vaccinated against SARS-CoV-2 and, if so, which children should be prioritised (particularly if vaccine resources are limited). To inform such deliberations, we sought to identify children and young people at highest risk of hospitalization from COVID-19. This study used the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) platform to undertake a national incident cohort analysis to investigate the risk of hospitalization among 5-17 years old living in Scotland in risk groups defined by the living risk prediction algorithm (QCOVID). A Cox proportional hazard model was used to derive hazard ratios (HR) and 95% confidence intervals (CIs) for the association between risk groups and COVID-19 hospital admission. Adjustments were made for age, sex, socioeconomic status, co-morbidity, and prior hospitalization.
AUTHOR(S) Nikolaos Karantaglis; Antonios Gkantaras; Despoina Iordanidou (et al.)
Vaccines remain the most rigorous and cost-effective weapon of the public health care system against infectious diseases. The development of safe and effective vaccines against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as an imperative response to the unprecedented morbidity and mortality of the Coronavirus Disease 2019 (COVID-19) pandemic and the subsequent immense pressure on health care systems, families and global society. Despite the typically mild disease course of SARS-CoV-2 in minors, the associated rare but potentially life-threatening complications, as well as the emergence of new highly transmissible variants, led promptly to the extension of COVID-19 vaccine clinical trials in children and adolescents. To date, various COVID-19 vaccine candidates have been successfully trialed in pediatric populations, followed by their incorporation into corresponding vaccination campaigns in both high- and low-income countries. However, the universal COVID-19 vaccination of children and adolescents remains a matter of debate, along with skepticism about their overall safety and benefits in this age group. This narrative review attempts to summarize the multi-faceted burden of COVID-19 on minors, highlighting the favourable safety/effectiveness profile of COVID-19 vaccines in this age group, elucidating the raised concerns and presenting the current implemented vaccination strategies.
AUTHOR(S) Laura M. Canaday; Jessica D. Resnick; Hsuan Liu (et al.)
AUTHOR(S) Swagat Kumar Das; Manish Paul; Bikash Chandra Behera (et al.)
Since its inception, Coronavirus disease-19 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has claimed a significant number of lives around the world. COVID-19 vaccine development involves several vaccine platforms, including traditional live-attenuated or killed viral particles, viral vectors or DNA, and mRNA-based vaccines. The efficacy and effectiveness (EV) of these vaccines must be assessed in order to determine the extent to which they can protect us against infection. Despite the fact that some affluent countries attempted to vaccinate the majority of their inhabitants, children and pregnant women were first excluded.
AUTHOR(S) Katharine J. Head; Gregory D. Zimet; Constantin T. Yiannoutsos (et al.)
AUTHOR(S) M. Shwethashree; A. Vanmathi; Saurish
The COVID-19 pandemic has created a lot of disruptions for delivery of health care services like routine immunization. Delayed immunization can lead to outbreak of many vaccine preventable diseases. The current pandemic created confusions and fear among mothers to vaccinate their children. This study was an initiative to understand the struggles faced by them during the pandemic. It aims to estimate the prevalence of hesitancy for routine immunization among urban mothers during COVID-19 pandemic and to determine the factors responsible for their hesitancy.
AUTHOR(S) Jun Cai; Juan Yang; Xiaowei Deng (et al.)
AUTHOR(S) Steven R. Kraaijeveld; Rachel Gur-Arie; Euzebiusz Jamrozik
AUTHOR(S) Mohammad Ali; Tasnuva Shamarukh Proma; Zarin Tasnim (et al.)
Little is known about parental coronavirus disease 2019 (COVID-19) vaccine hesitancy in children with neurodevelopmental disorders (NDD). This survey estimated the prevalence and predictive factors of vaccine hesitancy among parents of children with NDD. A nationally representative cross-sectional survey was conducted from October 10 to 31, 2021. A structured vaccine hesitancy questionnaire was used to collect data from parents aged ≥ 18 years with children with NDD. In addition, individual face-to-face interviews were conducted at randomly selected places throughout Bangladesh. Multiple logistic regression analysis was conducted to identify the predictors of vaccine hesitancy.
AUTHOR(S) N. Kuciel; J. Mazurek; K. Hap (et al.)
The World Health Organization indicated vaccine hesitancy as one of the top 10 threats to global health. The success of a vaccine depends not only on its efficacy but also on its acceptance. This study aims to define COVID-19 vaccine acceptance in a sample of pregnant and lactating women in Poland. Since mothers are often key decision-makers for whether their children will receive vaccination, it is vital to measure vaccine confidence among this group. An anonymous online survey was distributed to assess the level of acceptance of COVID-19 vaccination among pregnant and lactating women for themselves and their children in Poland.
AUTHOR(S) Chloe A. Teasdale; Luisa N. Borrell; Yanhan Shen (et al.)
AUTHOR(S) Samantha Schilling; Colin J. Orr; Alan M. Delamater (et al.)
AUTHOR(S) Diana Reindl; Serkan Catma
This study uses the Health Belief Model (HBM) to explain parents’ willingness to vaccinate (WTV) their children with COVID-19 vaccine in the United States (US). The analysis included determining if vaccination choice among parents statistically varied based on geography among the sample collected. A cross-sectional survey was administered on November 2020. Multiple regression analysis was completed, determining which HBM constructs to be most relevant to parents’ WTV their children with COVID-19 vaccine. To determine ‘hot’ and ‘cold’ geographic spots for WTV, a hot spot analysis based on Getis-Ord Gi* statistics was executed.
AUTHOR(S) Petros Galanis; Irene Vraka; Olga Siskouc (et al.)
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Subscribe to updates on new research about COVID-19 & children
Check our quarterly thematic digests on children and COVID-19
COVID-19 & Children: Rapid Research Response
